Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT05230472 Completed - Clinical trials for VAP - Ventilator Associated Pneumonia

Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia

Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

Statins with their powerful anti-inflammatory, immunomodulatory, and antioxidant properties make them candidate members to be used in the management of sepsis and different types of infections including pneumonia. This study aims to determine whether adjunctive statin therapy decreased day- 28 mortality among ICU patients with ventilator-associated pneumonia (VAP) & number of ventilator-free days (after successful weaning) between day 1 and both day 28.

NCT ID: NCT05229276 Completed - Clinical trials for Coronary Artery Disease

Efficacy of Sternum Guard in Post Cardiac Surgery Patient

Start date: May 17, 2020
Phase: N/A
Study type: Interventional

This is a single-center, single-blind, randomized parallel superiority trial comparing two groups; Sternum GuardTM as the treatment arm and Bone Wax as the active control group. Both investigated modalities are materials used during sternotomy for covering the sewn sternal edge. The primary outcomes of this study comprised of four parameters; namely surgical site infection (superficial or deep infection), sternal dehiscence, hemostatic effect, and surgeon's satisfaction rate. The first three primary outcomes were assessed during the operation, at the end of the hospital stay, 14 days, and 30-days postoperative.

NCT ID: NCT05229237 Completed - Clinical trials for Polypoidal Choroidal Vasculopathy

Conbercept for Polypoidal Choroidal Vasculopathy(START Study)

Start date: May 1, 2018
Phase:
Study type: Observational [Patient Registry]

1. To evaluate the effectiveness of Conbercept for PCV patients. 2. To describe the characteristics of PCV. 3. To describe the adverse events (AE) of Conbercept in the treatment of PCV. 4. Todescirbe the real situation and prognosis of PCV patients in our country.

NCT ID: NCT05229172 Completed - Clinical trials for Respiratory Insufficiency in Children

Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG)

PaVoG
Start date: February 24, 2022
Phase:
Study type: Observational

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product and will provide performance data on the Volume Guarantee function of the fabian ventilator in daily clinical routine.

NCT ID: NCT05229042 Completed - Clinical trials for Peripheral Nervous System Diseases

A Study to Investigate the Safety and Efficacy of Ricolinostat

Start date: January 1, 2022
Phase: Phase 1
Study type: Interventional

This is a double-blind, placebo-controlled study during which patients will receive ricolinostat or placebo.

NCT ID: NCT05227300 Completed - Clinical trials for Symptomatic Irreversible Pulpitis

Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis

Start date: February 14, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether one type of anesthetic (numbing medicine) will work better at numbing the nerve in a tooth than using a different type of anesthetic. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.

NCT ID: NCT05227027 Completed - Clinical trials for Cigarette Smoking-Related Carcinoma

Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation

Start date: February 9, 2022
Phase: N/A
Study type: Interventional

This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and efficacy. Video games are designed to increase users' motivation and engagement, which in turn may increase their exposure and adherence to a smoking cessation program. The hypothesis is that the game increases engagement, retention, and smoking abstinence rates compared with a core version of the app without the game. A two-arm individually randomized pilot trial of 500 adult smokers will test this hypothesis, comparing outcomes for participants randomized to receive the core app plus embedded game with participants randomized to receive the core app only. Primary outcomes relate to user engagement with the app. Secondary outcomes relate to user engagement, efficacy (smoking abstinence), and user satisfaction.

NCT ID: NCT05226949 Completed - Neonatal Sepsis Clinical Trials

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Start date: January 1, 2022
Phase:
Study type: Observational

This study seeks to identify and test host RNA expression profiles in context to protein biomarkers in dried blood spot samples as novel diagnostic markers of neonatal herpes simplex virus infection and to improve the understanding of the pathogenesis of the disease.

NCT ID: NCT05226715 Completed - Healthy Clinical Trials

Effect of Lower Extremity Joint Manipulation on a Lower Extremity Somatosensory Illusion

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the influence of extremity manipulation on individual's center of pressure after they adapt to an ankle based illusion.

NCT ID: NCT05226403 Completed - Covid19 Clinical Trials

COVID-19 : Pulmonary Ultrasound in Primary Care

ECHOVID-MG
Start date: July 1, 2020
Phase:
Study type: Observational

COVID-19 infection are characterized by fever and signs of acute respiratory infection. A worsening of respiratory symptoms that can lead to respiratory failure. The decompensation can then be brutal and require rapid recourse to respiratory assistance. The contribution of clinical examination (auscultation and monitoring of oxygen saturation in particular) remains unsatisfactory in predicting an unfavorable course. The interest of pulmonary ultrasound is known in the management of pulmonary infections. However, estimating the severity of lung damage at an early stage could be of great help in monitoring and caring for patients. Ultrasound could meet this need in general practice, the chest scanner is often unavailable in these situations. Ultrasound signs are associated with severe forms. The contribution of pulmonary ultrasound seems particularly interesting in the context of the reassessment of patients during the worsening phase of symptoms (D5-D10). Estimate the prevalence of ultrasound signs in patients with an acute respiratory infection suspected or confirmed to be COVID-19, at the time of the worsening phase (between D5 and D10 of the onset of symptoms). The prevalence of ultrasound lung lesions under COVID-19 may be essential to consider the development of the ultrasound tool in primary care. Indeed, if the contribution of ultrasound is now recognized in intensive care or emergency, its place in general medicine still raises questions.